Repository logo
 

Cycles of autoubiquitination and deubiquitination regulate the ERAD ubiquitin ligase Hrd1.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Glaser, Morgan L 

Abstract

Misfolded proteins in the lumen of the endoplasmic reticulum (ER) are retrotranslocated into the cytosol and polyubiquitinated before being degraded by the proteasome. The multi-spanning ubiquitin ligase Hrd1 forms the retrotranslocation channel and associates with three other membrane proteins (Hrd3, Usa1, Der1) of poorly defined function. The Hrd1 channel is gated by autoubiquitination, but how Hrd1 escapes degradation by the proteasome and returns to its inactive ground state is unknown. Here, we show that autoubiquitination of Hrd1 is counteracted by Ubp1, a deubiquitinating enzyme that requires its N-terminal transmembrane segment for activity towards Hrd1. The Hrd1 partner Hrd3 serves as a brake for autoubiquitination, while Usa1 attenuates Ubp1's deubiquitination activity through an inhibitory effect of its UBL domain. These results lead to a model in which the Hrd1 channel is regulated by cycles of autoubiquitination and deubiquitination, reactions that are modulated by the other components of the Hrd1 complex.

Description

Funder: Howard Hughes Medical Institute; FundRef: http://dx.doi.org/10.13039/100000011

Keywords

ERAD, S. cerevisiae, biochemistry, cell biology, chemical biology, protein degradation, protein quality control, regulation, Endoplasmic Reticulum, Endoplasmic Reticulum-Associated Degradation, Enzyme Stability, Intracellular Membranes, Membrane Glycoproteins, Protein Domains, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Ubiquitin-Protein Ligases, Ubiquitination

Journal Title

Elife

Conference Name

Journal ISSN

2050-084X
2050-084X

Volume Title

Publisher

eLife Sciences Publications, Ltd
Sponsorship
National Institute of General Medical Sciences (R35GM128592)
National Institute of General Medical Sciences (R01GM052586)
Damon Runyon Cancer Research Foundation (DRG-2184-14)
Damon Runyon Cancer Research Foundation (DFS-26-18)
University of Michigan Medical School (Biological Sciences Scholars Program)
National Institute of General Medical Sciences (Michigan Predoctoral Training in Genetics (T32GM007544))